<?xml version="1.0" encoding="UTF-8"?><edgarSubmission xmlns="http://www.sec.gov/edgar/ownership" xmlns:com="http://www.sec.gov/edgar/common">
  <headerData>
    <submissionType>144</submissionType>
    <filerInfo>
      <filer>
        <filerCredentials>
          <cik>0001248093</cik>
          <ccc>XXXXXXXX</ccc>
        </filerCredentials>
      </filer>
      <liveTestFlag>LIVE</liveTestFlag>



    </filerInfo>
  </headerData>
  <formData>
    <issuerInfo>
      <issuerCik>0001515673</issuerCik>
      <issuerName>Ultragenyx Pharmaceutical Inc.</issuerName>
      <secFileNumber>001-36276</secFileNumber>
      <issuerAddress>
        <com:street1>60 LEVERONI COURT</com:street1>
        <com:city>NOVATO</com:city>
        <com:stateOrCountry>CA</com:stateOrCountry>
        <com:zipCode>94949</com:zipCode>
      </issuerAddress>
      <issuerContactPhone>415-483-8800</issuerContactPhone>
      <nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>KAKKIS EMIL D</nameOfPersonForWhoseAccountTheSecuritiesAreToBeSold>
      <relationshipsToIssuer>
        <relationshipToIssuer>Officer</relationshipToIssuer>
      </relationshipsToIssuer>
    </issuerInfo>
    <securitiesInformation>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <brokerOrMarketmakerDetails>
        <name>MERRILL LYNCH</name>
        <address>
          <com:street1>555 CALIFORNIA STREET</com:street1>
          <com:street2>9TH FL</com:street2>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </address>
      </brokerOrMarketmakerDetails>
      <noOfUnitsSold>25000</noOfUnitsSold>
      <aggregateMarketValue>1062100.00</aggregateMarketValue>
      <noOfUnitsOutstanding>92501126</noOfUnitsOutstanding>
      <approxSaleDate>02/28/2025</approxSaleDate>
      <securitiesExchangeName>NASDAQ</securitiesExchangeName>
    </securitiesInformation>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>04/27/2010</acquiredDate>
      <natureOfAcquisitionTransaction>FOUNDERS SHARES</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ULTRAGENYX PHARMACEUTICAL, INC</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>18256</amountOfSecuritiesAcquired>
      <paymentDate>04/27/2010</paymentDate>
      <natureOfPayment>CASH</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>08/28/2017</acquiredDate>
      <natureOfAcquisitionTransaction>STOCK BONUS</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ULTRAGENYX PHARMACEUTICAL, INC</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>1454</amountOfSecuritiesAcquired>
      <paymentDate>08/28/2017</paymentDate>
      <natureOfPayment>CASH</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>09/11/2019</acquiredDate>
      <natureOfAcquisitionTransaction>STOCK BONUS</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ULTRAGENYX PHARMACEUTICAL, INC</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>5000</amountOfSecuritiesAcquired>
      <paymentDate>09/11/2019</paymentDate>
      <natureOfPayment>CASH</natureOfPayment>
    </securitiesToBeSold>
    <securitiesToBeSold>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <acquiredDate>04/29/2022</acquiredDate>
      <natureOfAcquisitionTransaction>STOCK BONUS</natureOfAcquisitionTransaction>
      <nameOfPersonfromWhomAcquired>ULTRAGENYX PHARMACEUTICAL, INC</nameOfPersonfromWhomAcquired>
      <isGiftTransaction>N</isGiftTransaction>
      <amountOfSecuritiesAcquired>290</amountOfSecuritiesAcquired>
      <paymentDate>04/29/2022</paymentDate>
      <natureOfPayment>CASH</natureOfPayment>
    </securitiesToBeSold>
    <nothingToReportFlagOnSecuritiesSoldInPast3Months>N</nothingToReportFlagOnSecuritiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>EMIL KAKKIS</name>
        <address>
          <com:street1>555 CALIFORNIA STREET</com:street1>
          <com:street2>9TH FLOOR</com:street2>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94104</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <saleDate>12/10/2024</saleDate>
      <amountOfSecuritiesSold>8273</amountOfSecuritiesSold>
      <grossProceeds>413650.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <securitiesSoldInPast3Months>
      <sellerDetails>
        <name>EMIL KAKKIS</name>
        <address>
          <com:street1>555 CALIFORNIA STREET, 9TH FLOOR</com:street1>
          <com:city>SAN FRANCISCO</com:city>
          <com:stateOrCountry>CA</com:stateOrCountry>
          <com:zipCode>94109</com:zipCode>
        </address>
      </sellerDetails>
      <securitiesClassTitle>COMMON</securitiesClassTitle>
      <saleDate>12/30/2024</saleDate>
      <amountOfSecuritiesSold>11727</amountOfSecuritiesSold>
      <grossProceeds>495264.00</grossProceeds>
    </securitiesSoldInPast3Months>
    <noticeSignature>
      <noticeDate>02/28/2025</noticeDate>
      <planAdoptionDates>
        <planAdoptionDate>03/01/2024</planAdoptionDate>
      </planAdoptionDates>
      <signature>EMIL KAKKIS</signature>
    </noticeSignature>
  </formData>
</edgarSubmission>
